Kimberly H. Allison

2004–2025 年に発表

79
論文数
27,339
被引用数
55
h 指数
78
i10 指数

被引用数

Kimberly H. Allison の年別被引用数1995 年: 被引用 1 件1999 年: 被引用 1 件2003 年: 被引用 1 件2005 年: 被引用 1 件2007 年: 被引用 4 件2008 年: 被引用 6 件2009 年: 被引用 19 件2010 年: 被引用 13 件2011 年: 被引用 28 件2012 年: 被引用 50 件2013 年: 被引用 39 件2014 年: 被引用 67 件2015 年: 被引用 116 件2016 年: 被引用 209 件2017 年: 被引用 271 件2018 年: 被引用 266 件2019 年: 被引用 837 件2020 年: 被引用 1,120 件2021 年: 被引用 1,223 件2022 年: 被引用 953 件2023 年: 被引用 820 件2024 年: 被引用 1,311 件2025 年: 被引用 604 件2026 年: 被引用 46 件1996〜1998 年は被引用が無いため表示していません2000〜2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,695 件、この内訳の 22.5%中国: 引用元論文 1,448 件、この内訳の 12.1%イタリア: 引用元論文 688 件、この内訳の 5.7%イギリス: 引用元論文 597 件、この内訳の 5%ドイツ: 引用元論文 477 件、この内訳の 4%フランス: 引用元論文 437 件、この内訳の 3.6%カナダ: 引用元論文 382 件、この内訳の 3.2%スペイン: 引用元論文 365 件、この内訳の 3%オーストラリア: 引用元論文 354 件、この内訳の 3%日本: 引用元論文 347 件、この内訳の 2.9%韓国: 引用元論文 345 件、この内訳の 2.9%ベルギー: 引用元論文 306 件、この内訳の 2.5%
0%22.5%その他 29.6%

分野

  • Medicine51.2%
  • Biochemistry, Genetics and Molecular Biology31.8%
  • Computer Science9%
  • Immunology and Microbiology3.3%
  • Engineering2%
  • Materials Science0.6%
  • その他2.1%

トピック

  • Breast Cancer Treatment Studies8%
  • Cancer Immunotherapy and Biomarkers6.4%
  • HER2/EGFR in Cancer Research4.9%
  • AI in cancer detection3.9%
  • Cancer Cells and Metastasis3.3%
  • Radiomics and Machine Learning in Medical Imaging3.1%
  • その他70.4%

共著者

全論文

検索で開く
  1. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 被引用: 3,136

  2. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 1,497

  3. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2022 被引用: 964

  4. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

    著者: , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 581

  5. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    著者: , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 被引用: 2,454

  6. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tari A. King, Charles M. Perou, Rehan Akbani, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Thomas Barr, Andrew H. Beck, Christopher C. Benz, Stephen C. Benz, Mario Berríos, Rameen Beroukhim, Tom Bodenheimer, Lori Boice, Lori Boice, Jay Bowen, Reanne Bowlby, Denise Brooks, Andrew D. Cherniack, Lynda Chin, Juok Cho, Sudha Chudamani, Giovanni Ciriello, Tanja M. Davidsen, John A. Demchok, Jennifer B. Dennison, Li Ding, Ina Felau, Martin L. Ferguson, Scott Frazer, Stacey Gabriel, Jianjiong Gao, Julie M. Gastier-Foster, Michael L. Gatza, Nils Gehlenborg, Mark Gerken, Gad Getz, William J. Gibson, D. Neil Hayes, David I. Heiman, Katherine A. Hoadley, Andrea Holbrook, Robert A. Holt, Alan P. Hoyle, Hai Hu, Mei Huang, Carolyn M. Hutter, E. Shelley Hwang, E. Shelley Hwang, Steven J.M. Jones, Zhenlin Ju, Jaegil Kim, Phillip H. Lai, Peter W. Laird, Michael S. Lawrence, Kristen M. Leraas, Tara M. Lichtenberg, Pei Lin, Shiyun Ling, Jia Liu, Wenbin Liu, Laxmi Lolla, Yiling Lu, Yussanne Ma, Dennis T. Maglinte, Elaine R. Mardis, Jeffrey R. Marks, Marco A. Marra, Cynthia McAllister, Michael D. McLellan ほか 60 名 - Cell 2015 被引用: 1,981

  7. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, Mei Wei, Kari B. Wisinski, Jessica Young, Kay T. Yeung, Mary A. Dwyer, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2023 被引用: 440

  8. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2020 被引用: 1,618

  9. The 2019 World Health Organization classification of tumours of the breast

    著者: , , , , , , , , , , , , , , , , , , - Histopathology 2020 被引用: 1,074

  10. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  11. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium

    著者: , , , , , , - Nature Materials 2014 被引用: 840

  12. Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens

    著者: , , , , , , , , , , , - JAMA 2015 被引用: 723

  13. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, Mei Wei, Kari B. Wisinski, Kay T. Yeung, Jessica Young, Ryan Schonfeld, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2024 被引用: 560

  14. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 347

  15. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  16. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2013 被引用: 4,061

  17. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

    著者: , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2020 被引用: 369

  18. Molecular analysis of TCGA breast cancer histologic types

    著者: , , , , , , , , , , , - Cell Genomics 2021 被引用: 116

  19. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2021 被引用: 351

  20. HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Summary

    著者: , , , , , - Journal of Oncology Practice 2018 被引用: 183

  21. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carlos Castaneda, Marleen Kok, Heather L. McArthur, Kalliopi P. Siziopikou, Sunil Badve, Susan Fineberg, Allen M. Gown, Giuseppe Viale, Stuart J. Schnitt, Giancarlo Pruneri, Frederique Penault‐Llorca, Stephen M. Hewitt, E. Aubrey Thompson, Kimberly H. Allison, W. Fraser Symmans, Andrew M. Bellizzi, Edi Brogi, David A. Moore, Denis Larsimont, Deborah Dillon, Alexander J. Lazar, Huang‐Chun Lien, Matthew P. Goetz, Glenn Broeckx, Khalid El Bairi, Nadia Harbeck, Ashley Cimino‐Mathews, Christos Sotiriou, Sylvia Adams, S Liu, Sibylle Loibl, I‐Chun Chen, Sunil R. Lakhani, Jonathan Juco, Carsten Denkert, Elizabeth F. Blackley, Sandra Demaria, Roberto A. Leon‐Ferre, Oleg Gluz, Dimitrios Zardavas, Kenneth Emancipator, Scott Ely, Sherene Loi, Roberto Salgado, Melinda E. Sanders, International Immuno‐Oncology Biomarker Working Group - The Journal of Pathology 2020 被引用: 226

  22. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues

    著者: , , , , , , , , , , , , , , - Clinical Chemistry 2021 被引用: 47

  23. Updates on breast biomarkers

    著者: , - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2022 被引用: 70

  24. Incidence of endometrial hyperplasia

    著者: , , , , , , , - American Journal of Obstetrics and Gynecology 2009 被引用: 219